剖宫产术同时进行子宫肌瘤剔除术治疗的临床效果分析

Analysis of the clinical effect of myomectomy in the process of cesarean section

目的分析妊娠合并子宫肌瘤患者在实施剖宫产术的同时进行子宫肌瘤剔除术治疗的临床效果。方法随机选择2015年7月至2016年7月在本院接受治疗的妊娠合并子宫肌瘤患者70例参与研究,随机将其均分成观察组(n=35)和对照组(n=35),对照组选择在剖宫产术后择期进行子宫肌瘤剔除术治疗,观察组选择在剖宫产术同时进行子宫肌瘤剔除术治疗,比较两组患者的治疗效果。结果观察组患者的手术时间长于对照组(P<0.05),但术中出血量、产后出血量、肛门排气时间、住院时间、宫缩素用量、术后血红蛋白水平、恶露持续时间、子宫复旧速度与对照组比较,差异无统计学意义(P>0.05);且观察组并发症发生率为5.71%,与对照组的8.57%比较,无明显差异(P>0.05)。结论妊娠合并子宫肌瘤患者在实施剖宫产术同时进行子宫肌瘤剔除术治疗,安全可行,值得推广。

Objective To analyze the clinical effect of myomectomy in the process of cesarean section in the treatment of patients with hysteromyoma. Methods From July 2015 to July 2016, 70 patients with hysteromyoma in our hospital were randomly selected, and all patients were randomly divided into observation group （n=35） and control group （n=35）. The control group received selective operation after the cesarean section, while the observation group received myomectomy in the process of cesarean section. The treatment effects were compared between the two groups. Results In the observation group, the operation time was longer than that of the control group （P〈0.05）. There were no significant differences in intraoperative blood loss, postpartum hemorrhage, anal exhaust time, length of stay, dosage of uterus, level of postoperative hemoglobin, duration of lochia and uterine recovery rate in the two groups （P〉0.05）. The incidence of complications was 5.71% in the observation group and 8.57% in the control group, and there was no significant difference in the two groups （P〉0.05）. Conclusion The myomectomy in the process of cesarean section for the treatment of patients with hysteromyoma is safe and feasible, which is worthy of application.